ArticleCancer medicine2025
Optimization of First-Line Treatment Options in HER2-Altered Lung Adenocarcinoma: A Real-World Study.
Xiufen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancer medicine2025
Xiufen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.